Lee, Danner & Bass’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.96M | Sell |
47,941
-681
| -1% | -$60.8K | 0.29% | 76 |
|
|
2026
Q1 | $3.49M | Sell |
48,622
-933
| -2% | -$71.9K | 0.22% | 91 |
|
|
2025
Q4 | $3.93M | Sell |
49,555
-659
| -1% | -$52K | 0.28% | 77 |
|
|
2025
Q3 | $3.79M | Sell |
50,214
-1,471
| -3% | -$101K | 0.28% | 79 |
|
|
2025
Q2 | $3.57M | Sell |
51,685
-3,692
| -7% | -$242K | 0.28% | 80 |
|
|
2025
Q1 | $3.75M | Sell |
55,377
-1,350
| -2% | -$80.8K | 0.3% | 72 |
|
|
2024
Q4 | $2.55M | Buy |
56,727
+247
| +0.4% | +$13.9K | 0.2% | 88 |
|
|
2024
Q3 | $3.55M | Sell |
56,480
-5,049
| -8% | -$295K | 0.25% | 79 |
|
|
2024
Q2 | $3.63M | Buy |
+61,529
| New | +$3.85M | 0.28% | 73 |
|
|
2023
Q4 | $8.09M | Sell |
102,464
-3,350
| -3% | -$238K | 0.69% | 34 |
|
|
2023
Q3 | $7.39M | Sell |
105,814
-1,723
| -2% | -$122K | 0.67% | 34 |
|
|
2023
Q2 | $7.43M | Buy |
107,537
+4,119
| +4% | +$293K | 0.64% | 35 |
|
|
2023
Q1 | $7.68M | Buy |
103,418
+8,197
| +9% | +$687K | 0.71% | 34 |
|
|
2022
Q4 | $8.87M | Buy |
95,221
+2,226
| +2% | +$215K | 0.84% | 32 |
|
|
2022
Q3 | $8.87M | Buy |
92,995
+1,040
| +1% | +$103K | 0.94% | 27 |
|
|
2022
Q2 | $8.52M | Sell |
91,955
-2,260
| -2% | -$221K | 0.86% | 31 |
|
|
2022
Q1 | $9.54M | Sell |
94,215
-1,284
| -1% | -$135K | 0.81% | 32 |
|
|
2021
Q4 | $9.85M | Sell |
95,499
-1,057
| -1% | -$97.7K | 0.84% | 30 |
|
|
2021
Q3 | $8.19M | Sell |
96,556
-2,117
| -2% | -$177K | 0.76% | 36 |
|
|
2021
Q2 | $8.23M | Buy |
98,673
+96
| +0.1% | +$7.86K | 0.75% | 36 |
|
|
2021
Q1 | $7.42M | Buy |
98,577
+1,418
| +1% | +$103K | 0.71% | 41 |
|
|
2020
Q4 | $6.64M | Buy |
97,159
+4,475
| +5% | +$291K | 0.71% | 39 |
|
|
2020
Q3 | $5.41M | Buy |
92,684
+14
| +0% | +$871 | 0.64% | 42 |
|
|
2020
Q2 | $6.02M | Buy |
92,670
+23,495
| +34% | +$1.48M | 0.77% | 34 |
|
|
2020
Q1 | $4.1M | Buy |
69,175
+7,844
| +13% | +$524K | 0.59% | 47 |
|
|
2019
Q4 | $4.56M | Buy |
61,331
+14,900
| +32% | +$1.05M | 0.48% | 56 |
|
|
2019
Q3 | $2.93M | Sell |
46,431
-1,671
| -3% | -$99K | 0.31% | 69 |
|
|
2019
Q2 | $2.62M | Sell |
48,102
-2,511
| -5% | -$135K | 0.28% | 71 |
|
|
2019
Q1 | $2.73M | Buy |
50,613
+5,536
| +12% | +$342K | 0.3% | 68 |
|
|
2018
Q4 | $2.95M | Buy |
45,077
+178
| +0.4% | +$13.3K | 0.35% | 66 |
|
|
2018
Q3 | $3.53M | Sell |
44,899
-2,313
| -5% | -$165K | 0.35% | 67 |
|
|
2018
Q2 | $3.04M | Buy |
47,212
+2,546
| +6% | +$168K | 0.32% | 72 |
|
|
2018
Q1 | $2.78M | Buy |
44,666
+4,885
| +12% | +$350K | 0.29% | 78 |
|
|
2017
Q4 | $2.88M | Sell |
39,781
-4,926
| -11% | -$358K | 0.29% | 79 |
|
|
2017
Q3 | $3.64M | Sell |
44,707
-3,027
| -6% | -$239K | 0.39% | 61 |
|
|
2017
Q2 | $3.84M | Buy |
47,734
+1,040
| +2% | +$82.1K | 0.43% | 59 |
|
|
2017
Q1 | $3.67M | Buy |
46,694
+2,253
| +5% | +$180K | 0.41% | 56 |
|
|
2016
Q4 | $3.51M | Sell |
44,441
-2,319
| -5% | -$188K | 0.41% | 56 |
|
|
2016
Q3 | $4.16M | Buy |
46,760
+11,153
| +31% | +$1.05M | 0.51% | 52 |
|
|
2016
Q2 | $3.41M | Buy |
35,607
+10,260
| +40% | +$1.02M | 0.41% | 58 |
|
|
2016
Q1 | $2.61M | Buy |
25,347
+605
| +2% | +$58.8K | 0.32% | 67 |
|
|
2015
Q4 | $2.42M | Buy |
24,742
+20,727
| +516% | +$2.03M | 0.32% | 66 |
|
|
2015
Q3 | $387K | Buy |
4,015
+800
| +25% | +$84.1K | 0.05% | 129 |
|
|
2015
Q2 | $337K | Hold |
3,215
| – | – | 0.04% | 142 |
|
|
2015
Q1 | $332K | Hold |
3,215
| – | – | 0.04% | 137 |
|
|
2014
Q4 | $310K | Buy |
3,215
+200
| +7% | +$17.6K | 0.04% | 140 |
|
|
2014
Q3 | $240K | Hold |
3,015
| – | – | 0.03% | 148 |
|
|
2014
Q2 | $227K | Buy |
+3,015
| New | +$228K | 0.03% | 151 |
|
Other funds holding CVS
Lee, Danner & Bass's CVS Position: Q2 2026 in Review
Lee, Danner & Bass reduced its CVS Health (CVS) stake by 1.4% in Q2 2026, selling an estimated $60.8K and leaving 47,941 shares worth $4.96M. The position accounts for 0.29% of the portfolio, ranked #76.
Lee, Danner & Bass first reported a position in CVS in Q2 2014 and has held it in 48 quarters since. The position peaked at $9.85M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Lee, Danner & Bass held 47,941 shares of CVS Health worth $4.96M as of Q2 2026.
- Lee, Danner & Bass sold 681 CVS Health shares in Q2 2026, an estimated $60.8K.
- CVS Health made up 0.29% of Lee, Danner & Bass's portfolio in Q2 2026, its #76 holding.
- Lee, Danner & Bass first reported a position in CVS Health in Q2 2014 and has held it in 48 quarters since.
- Lee, Danner & Bass's CVS Health position peaked at $9.85M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Lee, Danner & Bass's 13F filing for Q2 2026, filed 21 Jul 2026.